S'abonner

Relationship of Ethnic Origin, Gender, and Age to Blood Creatine Kinase Levels - 12/08/11

Doi : 10.1016/j.amjmed.2008.08.033 
Ryan C. Neal, MD a, , Keith C. Ferdinand, MD b, Joseph Yčas, PhD c, Elinor Miller, MD c
a Baylor College of Medicine, Houston, Tex 
b Association of Black Cardiologists, Inc, Atlanta, Ga 
c AstraZeneca LP, Wilmington, Del 

Requests for reprints should be addressed to Ryan C. Neal, MD, Diagnostic Clinic of Houston, 1200 Binz Street, Suite 700, Houston, TX 77030

Abstract

Background

Creatine kinase is expressed at high levels in muscle, where it plays a central role in energy metabolism. Highly elevated creatine kinase levels in blood may indicate muscle trauma or disease. However, it is known that baseline creatine kinase levels are higher in African Americans than in whites and that they are higher in men than in women. This analysis explores the relationship of ethnic origin, gender, and age to baseline blood creatine kinase levels in a large group of adults with hypercholesterolemia.

Methods

Data from the screening phases of 4 North American trials of statins, which included large numbers of specific racial/ethnic populations, were combined for analysis. The pooled population (N=11,346) included 2760 African Americans, 3301 whites, 2930 Hispanics, and 2355 South Asians.

Results

Creatine kinase levels varied according to ethnic origin, gender, and age. African American participants had higher median creatine kinase levels than did individuals of the 3 other ethnicities. Within each ethnic group, men had higher median creatine kinase levels than women: African Americans, 135 versus 73 U/L; whites, 64 versus 42 U/L; Hispanics, 69 versus 48 U/L; and South Asians, 74 versus 50 U/L. An age-dependent decrease in creatine kinase levels was noted among men, but no such trend was seen among women. The median creatine kinase levels for younger African American men exceeded the standard upper limit of normal.

Conclusion

Physicians should use caution when interpreting creatine kinase levels that seem elevated, particularly when treating African American patients and younger men.

Le texte complet de cet article est disponible en PDF.

Keywords : Age, Creatine kinase, Gender, Race, Variation


Plan


 Funding: The ARIES, IRIS, SOLAR, and STARSHIP studies, as well as this analysis of pooled screening data, were funded by AstraZeneca LP, Wilmington, Delaware.
 Conflict of Interest: Dr Neal is an active member of the Speakers' Bureau and consultant for AstraZeneca, with honoraria exceeding $50,000. Dr Ferdinand is an AstraZeneca consultant and member of the Speakers' Bureau, with honoraria totaling $50,000 for the past 3 years. Drs Yčas and Miller are employees of AstraZeneca.
 Authorship: All authors had full access to the data and played a role in writing this article.


© 2009  Elsevier Inc. Tous droits réservés.
Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 122 - N° 1

P. 73-78 - janvier 2009 Retour au numéro
Article précédent Article précédent
  • The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study
  • Mohamed G. Atta, Kesha Baptiste-Roberts, Frederick L. Brancati, Tiffany L. Gary
| Article suivant Article suivant
  • Electrocardiography Screening for Cardiotoxicity after Modified Vaccinia Ankara Vaccination
  • Junko Sano, Bernard R. Chaitman, Jason Swindle, Sharon E. Frey

Déjà abonné à cette revue ?